Locoregional Therapy (LRT) + Systemic Drug Therapy

COMBINATION_PRODUCT2 trials

Sponsors

Ningbo Medical Center Lihuili Hospital

Conditions

Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectableLiver Transplantation

Unknown Phase

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

Not yet recruitingNCT07310836

Ningbo Medical Center Lihuili HospitalHepatocellular Carcinoma, Liver Transplantation

Start: 2025-12-20End: 2026-03-31Target: 300Updated: 2025-12-30

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma

Not yet recruitingNCT07368023

Ningbo Medical Center Lihuili HospitalHepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable

Start: 2026-01-25End: 2026-05-31Target: 300Updated: 2026-01-26